Immunomodulating nanomedicine for cancer therapy

Zhigang Liu, Wen Jiang, Jutaek Nam, James J. Moon, Y S Betty Kim

Research output: Contribution to journalArticle

28 Scopus citations


Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics. For immuno-oncology applications, cancer nanomedicine should be developed beyond drug-delivery platforms. A greater emphasis on actively modulating host anticancer immunity using nanomaterials provides new avenues for developing novel cancer therapeutics.

Original languageEnglish (US)
JournalNano Letters
StateAccepted/In press - Jan 1 2018


  • cancer immunotherapy
  • cancer vaccine
  • drug delivery
  • Nanomedicine
  • nanotechnology

ASJC Scopus subject areas

  • Bioengineering
  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering

Fingerprint Dive into the research topics of 'Immunomodulating nanomedicine for cancer therapy'. Together they form a unique fingerprint.

  • Cite this